Intellia Therapeutics Inc (FRA:38I)
€ 13.565 -0.175 (-1.27%) Market Cap: 1.44 Bil Enterprise Value: 903.64 Mil PE Ratio: 0 PB Ratio: 1.53 GF Score: 57/100

Q4 2019 Intellia Therapeutics Inc Earnings Call Transcript

Feb 27, 2020 / 01:00PM GMT
Release Date Price: €11 (-2.96%)
Operator

Good morning. My name is Andrew, and I will be your conference operator today, and welcome to the Intellia Therapeutics Fourth Quarter and Full Year 2019 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request. (Operator Instructions)

At this time, I would like to turn it over to Lina Li, Associate Director of Investor Relations at Intellia. Please proceed.

Lina Li
Intellia Therapeutics, Inc. - Associate Director of IR

Thank you, operator. Good morning, and thank you all for joining us today to discuss Intellia's Fourth Quarter and Full Year 2019 Operational Highlights and Financial Results.

Earlier this morning, we issued a press release outlining our progress this quarter and the topics we plan to discuss on today's call. This release can be found on the Investors section of our website at www.intelliatx.com. This call is being broadcast live and a replay will also be archived on our website.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot